{"id":"l-arginine","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":null,"_dailymed":{"setId":"7b15d6fa-eb04-41d2-8a01-6e7408ccf4d3","title":"VITAL FEMALE SEXUAL ENERGY (AGNUS CASTUS, ARNICA MONTANA, AVENA SATIVA, CAULOPHYLLUM THALICTROIDES, CINCHONA OFFICINALIS, DAMIANA, HYPOPHYSIS SUIS, L-ARGININE, NATRUM MURIATICUM, OOPHORINUM SUIS, PHOSPHORICUM ACIDUM, SABAL SERRULATA, SEPIA, THUJA OCCIDENTALIS) SPRAY [LIDDELL LABORATORIES, INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"L-Arginine is converted to nitric oxide (NO) and L-citrulline by the enzyme nitric oxide synthase. Nitric oxide acts as a vasodilator, improving endothelial function and blood flow. It also plays roles in immune function, wound healing, and protein synthesis.","oneSentence":"L-Arginine is a semi-essential amino acid that serves as a substrate for nitric oxide synthase, increasing nitric oxide production to improve vascular function and blood flow.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:22:04.948Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cardiovascular dysfunction and endothelial dysfunction"},{"name":"Immune support and wound healing"},{"name":"Erectile dysfunction"}]},"trialDetails":[{"nctId":"NCT04569591","phase":"NA","title":"DDAVP for Pituitary Adenoma","status":"RECRUITING","sponsor":"National Institute of Neurological Disorders and Stroke (NINDS)","startDate":"2026-03-09","conditions":"Cushing's Disease, Pituitary Adenoma","enrollment":22},{"nctId":"NCT04040634","phase":"NA","title":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Israelita Albert Einstein","startDate":"2019-08-08","conditions":"Diabetes Mellitus, High Blood Pressure, Cardiovascular Diseases","enrollment":9476},{"nctId":"NCT06883422","phase":"NA","title":"Pre-Surgical Immunonutrition's Effect on Colorectal Surgery","status":"RECRUITING","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2023-05-25","conditions":"Colorectal Surgery","enrollment":126},{"nctId":"NCT06991738","phase":"PHASE1, PHASE2","title":"177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Thyroid Cancer","enrollment":18},{"nctId":"NCT06439875","phase":"NA","title":"Effects of L-arginine and Liposomial Vitamin C on Severe Copd Patients Undergoing Pulmonary Rehabilitation.","status":"COMPLETED","sponsor":"Istituti Clinici Scientifici Maugeri SpA","startDate":"2024-07-16","conditions":"Chronic Obstructive Pulmonary Disease, Respiratory Failure","enrollment":101},{"nctId":"NCT06337838","phase":"PHASE3","title":"Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2025-06-09","conditions":"Chronic Kidney Diseases, Acute Kidney Injury, Bleeding","enrollment":100},{"nctId":"NCT07393360","phase":"NA","title":"Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2025-12-11","conditions":"Obesity & Overweight","enrollment":144},{"nctId":"NCT06085729","phase":"PHASE1, PHASE2","title":"Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)","status":"SUSPENDED","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-02-29","conditions":"Prostate Cancer","enrollment":30},{"nctId":"NCT04278768","phase":"PHASE1, PHASE2","title":"Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)","status":"SUSPENDED","sponsor":"Curis, Inc.","startDate":"2020-07-06","conditions":"Acute Myelogenous Leukemia, Myelodysplastic Syndrome","enrollment":366},{"nctId":"NCT06960148","phase":"PHASE3","title":"Dentinal Hypersensitivity Reduction Efficacy Study","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2025-03-04","conditions":"Sensitivity, Tooth","enrollment":95},{"nctId":"NCT05813327","phase":"PHASE1","title":"Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2024-03-14","conditions":"Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue","enrollment":6},{"nctId":"NCT07292753","phase":"NA","title":"Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-12-15","conditions":"Nocturnal Enuresis, Vitamin D Deficiency","enrollment":90},{"nctId":"NCT07110532","phase":"PHASE1","title":"pH1N1 Blinded Challenge Study","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-09-10","conditions":"Influenza","enrollment":180},{"nctId":"NCT07466758","phase":"PHASE2","title":"Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients","status":"COMPLETED","sponsor":"Biruni University","startDate":"2024-10-16","conditions":"Myosteatosis, Sarcopenia","enrollment":40},{"nctId":"NCT06379217","phase":"PHASE1","title":"NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-07-29","conditions":"Metastatic Neuroendocrine Prostate Cancer","enrollment":31},{"nctId":"NCT03953326","phase":"PHASE1, PHASE2","title":"HeartPhone Cancer Survivors Trial 2019","status":"TERMINATED","sponsor":"Penn State University","startDate":"2019-04-23","conditions":"Breast Cancer, Leukemia, Lymphoma","enrollment":2},{"nctId":"NCT06426407","phase":"","title":"Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2025-10-01","conditions":"Shock, Septic","enrollment":2},{"nctId":"NCT05306925","phase":"NA","title":"An Exploratory Study of Arginine Supplementation and the Postoperative Immune REsponse","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2022-04-14","conditions":"Preterm, Surgery, Nutritional Deficiency","enrollment":48},{"nctId":"NCT05660083","phase":"PHASE2","title":"Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2023-01-12","conditions":"HER2-negative Breast Cancer, Metastatic Breast Cancer, Metaplastic Breast Carcinoma","enrollment":36},{"nctId":"NCT06504446","phase":"PHASE2","title":"Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough","status":"RECRUITING","sponsor":"Nocion Therapeutics","startDate":"2024-09-24","conditions":"Refractory or Unexplained Chronic Cough","enrollment":455},{"nctId":"NCT07276152","phase":"NA","title":"Plasma Oxytocin Changes in Response to Music Modified by Sonic Augmentation Technology","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2026-01-09","conditions":"Sonic Augmentation Technology","enrollment":22},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT04711135","phase":"PHASE2","title":"Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Advanced Accelerator Applications","startDate":"2022-08-31","conditions":"Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma","enrollment":11},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT06365047","phase":"PHASE3","title":"Dry Mouth Toothpaste Study - Comparing Two Toothpastes With Arginine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tufts University","startDate":"2024-08-31","conditions":"Xerostomia","enrollment":70},{"nctId":"NCT07134231","phase":"PHASE3","title":"Clinical Study to Evaluate the Anti-cavity Efficacy of Three Dentifrices: An In Situ Model","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2025-10-09","conditions":"Demineralization, Remineralization, Dental Cavity","enrollment":36},{"nctId":"NCT07394270","phase":"PHASE2","title":"Effect of Add-on L-Arginine Therapy on Heart Failure Patients","status":"NOT_YET_RECRUITING","sponsor":"German University in Cairo","startDate":"2026-02","conditions":"Heart Failure","enrollment":200},{"nctId":"NCT06344442","phase":"PHASE3","title":"Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-04-16","conditions":"Acute Kidney Injury Post Liver Transplantation","enrollment":304},{"nctId":"NCT07389278","phase":"PHASE1, PHASE2","title":"Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)","status":"NOT_YET_RECRUITING","sponsor":"Sabine Mueller, MD, PhD","startDate":"2026-03-09","conditions":"Glioblastoma, High-Grade Glioma (WHO III-IV), High-grade Glioma","enrollment":97},{"nctId":"NCT05616624","phase":"PHASE1, PHASE2","title":"ADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-04-05","conditions":"Non Small Cell Lung Cancer, Non-small Cell Lung Cancer, Small-cell Lung Cancer","enrollment":31},{"nctId":"NCT07020754","phase":"PHASE2","title":"Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Radiation Induced Oral Mucositis, Oral Mucositis, Oral Mucositis Due to Radiation","enrollment":84},{"nctId":"NCT05477134","phase":"NA","title":"Arginine Metabolism in Youth With Type 2 Diabetes","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2023-02-06","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT05190744","phase":"PHASE2","title":"Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2022-09-01","conditions":"Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus","enrollment":36},{"nctId":"NCT05470998","phase":"PHASE3","title":"L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-07-25","conditions":"Sickle Cell Disease","enrollment":50},{"nctId":"NCT07338682","phase":"PHASE2","title":"Evaluation of the Effect of L-Arginine on the Cognitive Function in Geriatric Patients","status":"RECRUITING","sponsor":"German University in Cairo","startDate":"2025-08-27","conditions":"Cognition Disorders in Old Age, Cognitive and Behavioral Impairment","enrollment":60},{"nctId":"NCT07277413","phase":"PHASE1","title":"A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors","status":"RECRUITING","sponsor":"IDEAYA Biosciences","startDate":"2026-02-28","conditions":"NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC), Gastric Adenocarcinoma","enrollment":260},{"nctId":"NCT07347509","phase":"NA","title":"Acute Effects of BCAA and L-Arginine on Performance in Elite Soccer Players","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-01-10","conditions":"Ergogenic Support and Performance","enrollment":21},{"nctId":"NCT07063680","phase":"PHASE3","title":"Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2026-01","conditions":"Patients With Norepinephrine-refractory Vasoplegic Shock","enrollment":390},{"nctId":"NCT05069402","phase":"NA","title":"Impact of Various Diets on Surgical Complications","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2021-09-01","conditions":"Complication,Postoperative","enrollment":300},{"nctId":"NCT06771128","phase":"NA","title":"Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2024-11-01","conditions":"Nocturnal Enuresis in Children, Desmopressin, Monosymptomatic Nocturnal Enuresis","enrollment":398},{"nctId":"NCT05706493","phase":"","title":"Association Between Periodontitis and the Level of Anti-citrullinated Protein Antibodies in Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Misr International University","startDate":"2024-03-01","conditions":"Periodontal Diseases, Rheumatoid Arthritis","enrollment":36},{"nctId":"NCT07155447","phase":"PHASE3","title":"Perioperative Nutrition Optimization for Reducing Complications After Surgical Fracture Fixation","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-06-01","conditions":"Lower Extremity Fracture","enrollment":1000},{"nctId":"NCT00227253","phase":"","title":"Chromosome 18 Clinical Research Center","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"1993-09","conditions":"Chromosome Aberrations, Growth Hormone Deficiency, Hypomyelination","enrollment":4000},{"nctId":"NCT06036004","phase":"PHASE2","title":"Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-01-08","conditions":"Central Diabetes Insipidus (cDI)","enrollment":112},{"nctId":"NCT05428007","phase":"PHASE2","title":"Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-02-02","conditions":"Melanoma, Unresectable Melanoma","enrollment":105},{"nctId":"NCT02850367","phase":"NA","title":"Effect of NO Precursors on Physiological Responses to Exercise","status":"COMPLETED","sponsor":"University Hospital, Grenoble","startDate":"2016-05-09","conditions":"Physiology","enrollment":63},{"nctId":"NCT00213915","phase":"PHASE4","title":"L-arginine Supplementation and Exercise; L-arginine Supplementation and Renal Function","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2004-02","conditions":"Heart Transplantation","enrollment":30},{"nctId":"NCT07150806","phase":"PHASE1, PHASE2","title":"RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma","status":"RECRUITING","sponsor":"Joshua Palmer","startDate":"2025-11-12","conditions":"Recurrent Meningioma","enrollment":30},{"nctId":"NCT05616273","phase":"","title":"Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Exeter","startDate":"2023-05-03","conditions":"Type 1 Diabetes, Hypoglycemia","enrollment":62},{"nctId":"NCT03573310","phase":"PHASE1","title":"A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-07-13","conditions":"Neoplasms, Solid Tumor, Adult, Non-Hodgkin Lymphoma","enrollment":114},{"nctId":"NCT05317819","phase":"PHASE3","title":"Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma","status":"RECRUITING","sponsor":"Polaris Group","startDate":"2022-03-14","conditions":"Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma","enrollment":300},{"nctId":"NCT06441331","phase":"PHASE1","title":"Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors","status":"RECRUITING","sponsor":"ITM Solucin GmbH","startDate":"2025-09-26","conditions":"Somatostatin Receptor Positive, NETs, Lymphoma","enrollment":20},{"nctId":"NCT07255378","phase":"","title":"Use of Vassopresin in Septic Shock Prospective Multicenter Observational Study With Medication","status":"RECRUITING","sponsor":"Jamil Cedeño Mora","startDate":"2025-10-01","conditions":"Septic Shock","enrollment":1200},{"nctId":"NCT06159608","phase":"EARLY_PHASE1","title":"Sex Differences in the Vascular Effects of E-cigarette Use","status":"RECRUITING","sponsor":"Anna Stanhewicz, PhD","startDate":"2023-12-02","conditions":"E-cigarette Use","enrollment":80},{"nctId":"NCT06542198","phase":"NA","title":"Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-09-10","conditions":"Polyuria-polydipsia Syndrome, Arginine Vasopressin Deficiency, Primary Polydipsia","enrollment":42},{"nctId":"NCT06778759","phase":"PHASE4","title":"Ibuprofen Arginine and Neural Mobilization Versus Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Universidad Europea de Madrid","startDate":"2025-02-19","conditions":"Carpal Tunnel Syndrome","enrollment":76},{"nctId":"NCT06781489","phase":"PHASE4","title":"Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine.","status":"COMPLETED","sponsor":"Universidad Europea de Madrid","startDate":"2025-02-19","conditions":"Carpal Tunnel Syndrome","enrollment":129},{"nctId":"NCT03449901","phase":"PHASE2","title":"ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2018-05-09","conditions":"Soft Tissue Sarcoma","enrollment":98},{"nctId":"NCT01023412","phase":"NA","title":"Effects of 3 Day Preoperative Immunonutrition in Well-nourished Patients With Gastrointestinal (GI) Cancer Undergoing Surgery","status":"TERMINATED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2006-01","conditions":"Gastrointestinal Cancer","enrollment":107},{"nctId":"NCT04025203","phase":"PHASE4","title":"Pain Reduction and Changes in Upper Limb Function Produced by Different Treatments in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Francisco Unda Solano","startDate":"2019-08-01","conditions":"Carpal Tunnel Syndrome","enrollment":196},{"nctId":"NCT04119739","phase":"PHASE4","title":"Pain Reduction Produced by Different Treatments in Carpal Tunnel Syndrome","status":"COMPLETED","sponsor":"Francisco Unda Solano","startDate":"2020-04-14","conditions":"Carpal Tunnel Syndrome","enrollment":117},{"nctId":"NCT07257042","phase":"PHASE3","title":"Oothpaste Containing 8% Arginine Compared to Colgate Cavity Protection Toothpaste in Reducing Dentinal Hypersensitivity","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2025-07-14","conditions":"Hypersensitivity","enrollment":80},{"nctId":"NCT03625349","phase":"","title":"Passive Limb Movement: A Tool to Assess Vascular Health and Guide Rehabilitation","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2015-09-01","conditions":"Aging, Cardiovascular Disease","enrollment":130},{"nctId":"NCT07240142","phase":"NA","title":"Neurotransmitter Levels in Children With Specific Learning Disorder","status":"COMPLETED","sponsor":"Dilara Ulger Ozbek","startDate":"2019-10-22","conditions":"Specific Learning Disability, Healthy (Controls)","enrollment":40},{"nctId":"NCT07115563","phase":"NA","title":"Daily Amino Acid Supplementation for People With Parkinson's Disease","status":"RECRUITING","sponsor":"Cristina Colon-Semenza","startDate":"2025-10-31","conditions":"Parkinson Disease (PD)","enrollment":30},{"nctId":"NCT07149376","phase":"PHASE3","title":"To Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity.","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2025-08-18","conditions":"Sensitivity, Tooth","enrollment":84},{"nctId":"NCT06148636","phase":"EARLY_PHASE1","title":"A Safety Study of 212Pb-VMT-alpha-NET in Patients With Neuroendocrine Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"David Bushnell","startDate":"2023-11-10","conditions":"Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Grade 1","enrollment":24},{"nctId":"NCT06633198","phase":"EARLY_PHASE1","title":"Heat, Microvascular Function and Aging","status":"RECRUITING","sponsor":"William Hughes","startDate":"2025-05-01","conditions":"Aging","enrollment":20},{"nctId":"NCT06635629","phase":"PHASE2","title":"Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-12-12","conditions":"Cushing Syndrome","enrollment":140},{"nctId":"NCT07210164","phase":"NA","title":"Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study","status":"RECRUITING","sponsor":"Aristotle University Of Thessaloniki","startDate":"2025-12-01","conditions":"ERAS, Compliance, Quality of Life (QOL)","enrollment":100},{"nctId":"NCT06808516","phase":"PHASE2","title":"Effects of Intranasal Oxytocin on Sexual Well-Being in Patients With Arginine Vasopressin Deficiency and Healthy Controls","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2025-07-01","conditions":"Arginine Vasopressin Deficiency, Central Diabetes Insipidus, Oxytocin Deficiency","enrollment":42},{"nctId":"NCT02337894","phase":"NA","title":"Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children","status":"WITHDRAWN","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2022-01-30","conditions":"Liver Steatosis, Insulin Resistance, Whole Body Protein Metabolism","enrollment":""},{"nctId":"NCT06137833","phase":"NA","title":"Wide Spectrum Micronutrients Supplementation in Patients With Cancer Related Fatigue During Neoadjuvant and Adjuvant Chemotherapy","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2023-11-27","conditions":"Fatigue, Breast Cancer","enrollment":92},{"nctId":"NCT05400733","phase":"NA","title":"Prandial Metabolic Phenotype in Adults","status":"RECRUITING","sponsor":"Texas A&M University","startDate":"2022-06-24","conditions":"Protein Metabolism","enrollment":50},{"nctId":"NCT02770092","phase":"NA","title":"CHF COPD Sip Feed Anabolic Response","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2016-02-10","conditions":"Pulmonary Disease, Chronic Obstructive, Congestive Heart Failure","enrollment":90},{"nctId":"NCT00497380","phase":"NA","title":"Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2009-08-18","conditions":"Protein Metabolism","enrollment":19},{"nctId":"NCT02733120","phase":"NA","title":"Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2015-12-03","conditions":"Autism Spectrum Disorder","enrollment":40},{"nctId":"NCT07199894","phase":"PHASE3","title":"Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2024-12-01","conditions":"Nocturnal Enuresis in Children","enrollment":120},{"nctId":"NCT02757638","phase":"NA","title":"Omics Profiling of Weight Loss With Bariatric Surgery","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2016-02-25","conditions":"Obesity, Surgery","enrollment":7},{"nctId":"NCT06731855","phase":"","title":"An Exploratory Physiological Study of Post-operative Recovery in Surgical Neonates and Dimethylarginine:Arginine Levels","status":"RECRUITING","sponsor":"Liverpool Women's NHS Foundation Trust","startDate":"2024-02-05","conditions":"Gastroschisis, Congenital Diaphragmatic Hernia, Duodenal Atresia","enrollment":30},{"nctId":"NCT02966665","phase":"PHASE1","title":": Vascular Function in Health and Disease","status":"RECRUITING","sponsor":"Russell Richardson","startDate":"2008-09","conditions":"Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Heart Failure","enrollment":420},{"nctId":"NCT07191665","phase":"","title":"Explore the Use of Cortical Oxygenation Measures in Nutrition Research","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2023-11-20","conditions":"Healthy","enrollment":37},{"nctId":"NCT05842512","phase":"PHASE2","title":"Study of ADI-PEG 20 Versus Placebo in Subjects With NASH","status":"RECRUITING","sponsor":"Polaris Group","startDate":"2023-09-13","conditions":"Nonalcoholic Steatohepatitis (NASH)","enrollment":60},{"nctId":"NCT03204786","phase":"PHASE2, PHASE3","title":"Intranasal Vasopressin Treatment in Children With Autism","status":"COMPLETED","sponsor":"Stanford University","startDate":"2018-02-20","conditions":"Autism, Autism Spectrum Disorder, ASD","enrollment":157},{"nctId":"NCT06860724","phase":"NA","title":"Linking Affective Dynamics in Response to Daily Stress to Peripheral Vascular Function in Working Age Adults","status":"RECRUITING","sponsor":"University of Delaware","startDate":"2025-01-06","conditions":"Major Depressive Disorder","enrollment":18},{"nctId":"NCT06328686","phase":"EARLY_PHASE1","title":"Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-09-05","conditions":"Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm","enrollment":10},{"nctId":"NCT04789148","phase":"PHASE1","title":"Effects of Intranasal Oxytocin in Patients With Arginine-vasopressin Deficiency","status":"RECRUITING","sponsor":"Elizabeth Austen Lawson","startDate":"2025-09-10","conditions":"Vasopressin Deficiency","enrollment":40},{"nctId":"NCT06280482","phase":"PHASE1","title":"Nicotinamide Riboside (NR) to Treat Moyamoya-like Cerebrovascular Disease in Smooth Muscle Dysfunction Syndrome (SMDS)","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2024-03-06","conditions":"Smooth Muscle Dysfunction Syndrome (SMDS)","enrollment":15},{"nctId":"NCT05651555","phase":"NA","title":"Evaluation of the EHPAD Caregiver/Pact & Pad Psycho-educational Program for Caregivers With an Institutionalized Parent","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-28","conditions":"Caregivers","enrollment":73},{"nctId":"NCT06622187","phase":"PHASE4","title":"Bleeding Prevention With Desmopressin for Allograft Kidney Biopsies","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2024-08-14","conditions":"Bleeding, Transplant, Kidney, Desmopressin","enrollment":96},{"nctId":"NCT07084948","phase":"PHASE4","title":"Using Flavonoids to Kill Hepatitis B Virus","status":"COMPLETED","sponsor":"Trieu, Nguyen Thi, M.D.","startDate":"2015-11-30","conditions":"Hepatitis B Virus Infection","enrollment":134},{"nctId":"NCT04919226","phase":"PHASE3","title":"Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE","status":"ACTIVE_NOT_RECRUITING","sponsor":"ITM Solucin GmbH","startDate":"2021-12-21","conditions":"Neuroendocrine Tumors","enrollment":259},{"nctId":"NCT05765487","phase":"PHASE1","title":"Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2023-05-13","conditions":"Sexual Arousal Disorder","enrollment":13},{"nctId":"NCT07152418","phase":"","title":"Therapeutic Efficacy of Monoclonal Antibody Drugs for Alzheimer's Disease Based on PET Research","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Alzheimer Disease (AD), Alzheimer Dementia, Mild Cognitive Impairment (MCI)","enrollment":120},{"nctId":"NCT06878664","phase":"PHASE3","title":"Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors","status":"RECRUITING","sponsor":"Grupo Espanol de Tumores Neuroendocrinos","startDate":"2025-06-12","conditions":"Grade1-2 Advanced Midgut Neuroendocrine Tumors (NETs)","enrollment":166},{"nctId":"NCT04587830","phase":"PHASE2","title":"ADI-PEG 20 Plus Radiotherapy and Temozolomide in Subjects With Glioblastoma Multiforme","status":"ACTIVE_NOT_RECRUITING","sponsor":"Polaris Group","startDate":"2020-09-14","conditions":"Glioblastoma Multiforme (GBM)","enrollment":100},{"nctId":"NCT06483737","phase":"NA","title":"Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":"Overt Hepatic Encephalopathy","enrollment":174},{"nctId":"NCT07135037","phase":"PHASE2","title":"Comparison Between Treatments of Oligohydramnios","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-09-01","conditions":"Oligohydramnios","enrollment":40},{"nctId":"NCT06573229","phase":"NA","title":"LIver FRAilty Management IN Cirrhosis (LIFRAMIN)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2024-08-02","conditions":"Sarcopenia, Cirrhosis, Liver, Malnutrition; Protein","enrollment":30},{"nctId":"NCT06732518","phase":"PHASE3","title":"Evaluation of the Anti-cavity Efficacy of Three Dentifrices Using an Intra-oral Enamel Demineralization - Remineralization In-Situ Model","status":"COMPLETED","sponsor":"Colgate Palmolive","startDate":"2025-03-13","conditions":"Enamel Lesions, Demineralization, Tooth, Remineralization","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":37762,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["2-Amino-5-guanidinopentanoic acid","Argimax","Placebo","Arginine 1000 (Jarrow Formulas, Los Angeles, CA)","Blue ox"],"phase":"marketed","status":"active","brandName":"L-Arginine","genericName":"L-Arginine","companyName":"The University of Texas at Arlington","companyId":"the-university-of-texas-at-arlington","modality":"Small molecule","firstApprovalDate":"","aiSummary":"L-Arginine is a semi-essential amino acid that serves as a substrate for nitric oxide synthase, increasing nitric oxide production to improve vascular function and blood flow. Used for Cardiovascular dysfunction and endothelial dysfunction, Immune support and wound healing, Erectile dysfunction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}